ex99-2_002.jpg
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
February 22, 2024 08:27 ET | Moringa Acquisition Corp
                                       Silexion’s first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer...
ex99-2_002.jpg
MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION
August 15, 2023 09:25 ET | Moringa Acquisition Corp
New York, NY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (Nasdaq: MACA) (“Moringa” or the “Company”) announced today that, in connection with its previously announced extraordinary...
ex99-2_002.jpg
MORINGA ACQUISITION CORP ANNOUNCES ADJOURNMENT OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO FEBRUARY 9, 2023
February 07, 2023 16:05 ET | Moringa Acquisition Corp
New York, NY, Feb. 07, 2023 (GLOBE NEWSWIRE) --  Moringa Acquisition Corp (Nasdaq: MACA) (“Moringa” or the “Company”) announced today that, the extraordinary general meeting in lieu of the 2022...
ex99-2_002.jpg
MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION
January 26, 2023 16:05 ET | Moringa Acquisition Corp
New York, NY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (Nasdaq: MACA)  (“Moringa” or the “Company”) announced today that, in connection with its previously announced...
ex99-2_001.jpg
Holisto, a Technology-Based Online Travel Booking Platform, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
June 13, 2022 17:09 ET | Moringa Acquisition Corp
Holisto’s advanced AI technology addresses the fragmented and complex travel booking market, providing consumers with a more affordable and personalized offeringSince commercial product launch in Q2...
Moringa Acquisition Corp Files its Annual Report for the 2021 Year
April 05, 2022 07:33 ET | Moringa Acquisition Corp
NEW YORK, NY, April 05, 2022 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NasdaqCM: MACA, MACAU and MACAW) (the “Company”) announced that it filed its annual report on Form 10-K for the year ended...
Moringa Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 7, 2021
April 05, 2021 16:05 ET | Moringa Acquisition Corp
NEW YORK, NY, April 05, 2021 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NasdaqCM: MACAU) (the “Company”) announced today that, commencing April 7, 2021, holders of the units sold in the Company’s...
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
February 16, 2021 16:54 ET | Moringa Acquisition Corp
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The units are...